Sclerosis clinical trials

Explore recruiting sclerosis clinical trials.

Recruiting sclerosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sclerosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of GLP-1 analogue in multiple sclerosis

Slovakia

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy, Safety, Tolerability, PK, and Biomarker Effects of PTC857 in Adult Subjects With Amyotrophic Lateral Sclerosis (CARDINALS)

Germany, Italy, Norway, Ireland, Sweden, Spain +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy, safety and cost-effectiveness of B cell tailored ocrelizumab versus standard ocrelizumab in relapsing remitting multiple sclerosis (BLOOMS): a randomized controlled trial

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

EFFICACY AND SAFETY OF CROMOGLYCATE AS A NEW SYMPTOMATIC TREATMENT IN PATIENTS WITH MULTIPLE SCLEROSIS

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Comparison of treatment efficacy in the patients with Systemic sclerOsis: dapagliFlozin vs. Tocilizumab – a randomized head to head study

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients with Progressive Multiple Sclerosis

Netherlands, Germany, Denmark, Poland, Czechia, France +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sclerosis trials by city

Sclerosis in Toronto Sclerosis in Vancouver Sclerosis in Montreal Sclerosis in Calgary Sclerosis in Edmonton Sclerosis in Ottawa Sclerosis in Winnipeg Sclerosis in Quebec City Sclerosis in Hamilton Sclerosis in Kitchener Sclerosis in London Sclerosis in Halifax Sclerosis in New York Sclerosis in Los Angeles Sclerosis in Chicago Sclerosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease